Experience

Davis Polk advised Equinix, Inc. on an SEC-registered offering of $2.8 billion aggregate principal amount of senior notes. The offering consisted of $1 billion aggregate principal amount of…

Davis Polk advised the underwriters in connection with the $439 million SEC-registered offering of common stock of Grocery Outlet Holding Corp. by certain existing stockholders of Grocery…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Harmonic Inc. of $115.5 million aggregate principal amount of its 2.00% convertible senior notes due…

Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point Therapeutics, Inc. Turning Point Therapeutics’ common stock is…

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal amount of 2.250% notes due 2029. Texas Instruments is a global…

Davis Polk advised the joint book-running managers and the lead manager in connection with a $258.8 million public offering of common stock by Portola Pharmaceuticals, Inc. The common stock…

Davis Polk advised CrowdStrike Holdings, Inc. on its SEC-registered initial public offering of 20,700,000 shares of Class A common stock for an aggregate price to the public of…

Davis Polk advised the underwriters in connection with the $8.1 billion initial public offering of 180,000,000 shares of common stock of Uber Technologies, Inc. Uber’s common stock is…

Davis Polk advised Equinix, Inc. on its SEC-registered follow-on public offering of 2,985,575 shares of common stock including 389,422 shares that the underwriters…

Davis Polk advised the joint book-running managers in connection with a $60 million SEC-registered common stock and pre-funded warrants offering by Aeglea BioTherapeutics, Inc. The common…